StockStory.org on MSN

The top 5 analyst questions from Exponent’s Q4 earnings call

Exponent delivered results ahead of Wall Street expectations in Q4, with management crediting growth in both proactive and ...
StockStory.org on MSN

Exponent’s (NASDAQ:EXPO) Q4 CY2025: Strong sales

Scientific consulting firm Exponent (NASDAQ:EXPO) reported in Q4 CY2025, with sales up 19.1% year on year to $147.4 million. Its GAAP profit of $0.49 per share was 3.7% above analysts’ consensus ...